Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity against Rhabdomyosarcoma with the Expression of Caspase-8 Predictive of Response
Zhigang Kang(Center for Drug Evaluation and Research), Liang Cao(National Human Genome Research Institute)
Cited by 42
Related Papers
Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and Cancer
|Cancer Research|2010|246
Toosendanin Exerts an Anti-Cancer Effect in Glioblastoma by Inducing Estrogen Receptor β- and p53-Mediated Apoptosis
|International Journal of Molecular Sciences|2016|51